|
Video: What is a Stock Split?
|
|
Baudax Bio is a pharmaceutical company primarily focused on commercializing and developing products for hospital and related acute care settings. Co. has launched its commercial product, ANJESO in the U.S. ANJESO is an intravenous analgesic agent. ANJESO is a cyclooxygenase-2 preferential, non-steroidal anti-inflammatory, or NSAID for the management of moderate to severe pain, which can be administered alone or in combination with other non-NSAID analgesics. Co.'s pipeline also includes other earlier stage product candidates including intermediate and short-acting neuromuscular blocking agents, and accompanying reversal agents that Co. is developing for use in hospital or related settings. According to our BXRX stock split history records, BXRX has had 2 splits. | |
|
BXRX (BXRX) has 2 splits in our BXRX stock split history database. The first split for BXRX took place on February 16, 2022. This was a 1 for 35 reverse split, meaning for each 35 shares of BXRX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 28.5714285714286 share position following the split. BXRX's second split took place on December 01, 2022. This was a 1 for 40 reverse split, meaning for each 40 shares of BXRX owned pre-split, the shareholder now owned 1 share. For example, a 28.5714285714286 share position pre-split, became a 0.714285714285714 share position following the split.
When a company such as BXRX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BXRX stock split history from start to finish, an original position size of 1000 shares would have turned into 0.714285714285714 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BXRX shares, starting with a $10,000 purchase of BXRX, presented on a split-history-adjusted basis factoring in the complete BXRX stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/15/2019 |
|
End date: |
11/20/2023 |
|
Start price/share: |
$8,844.00 |
|
End price/share: |
$0.08 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-94.49% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.09 |
|
Years: |
4.02 |
|
|
|
Date |
Ratio |
02/16/2022 | 1 for 35 | 12/01/2022 | 1 for 40 |
|
|